Xtx Topco LTD Acadia Pharmaceuticals Inc Transaction History

Xtx Topco LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$14.62 - $18.42 $533,922 - $672,698	36,520 New	36,520 $593,000
Q4 2023 Feb 13, 2024	SELL	$20.78 - $31.77 $477,150 - $729,502	-22,962 Reduced 63.92%	12,961 $405,000
Q3 2023 Nov 13, 2023	BUY	$20.84 - $33.47 $748,635 - $1.2 Million	35,923 New	35,923 $748,000
Q1 2023 May 12, 2023	BUY	$16.32 - $20.92 $109,115 - $139,871	6,686 Added 27.21%	31,261 $588,000
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $200,163 - $262,608	-14,096 Reduced 36.45%	24,575 $391,000
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $545,647 - $706,519	38,671 New	38,671 $633,000
Q3 2021 Nov 12, 2021	SELL	$15.78 - $24.77 $187,829 - $294,837	-11,903 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$19.4 - $27.42 $230,918 - $326,380	11,903 New	11,903 $290,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.